Effect of Switching Drug Formulations from Immediate-Release to Extended-Release OROS Methylphenidate: A Chart Review of Spanish Adults with Attention-Deficit Hyperactivity Disorder

Author： Josep Antoni Ramos-Quiroga   Bosch Rosa   Castells Xavier   Valero Sergi   Nogueira Mariana   Gómez Nuria   Yelmo Silvia   Ferrer Marc   Martínez Yolanda   Casas Miguel  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.22, Iss.7, 2008-01, pp. : 603-611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting Methylphenidate-OROS in Youths with Attention-Deficit Hyperactivity Disorder Suboptimally Controlled with Immediate-Release Methylphenidate: A Study of Cost Effectiveness in The Netherlands

By Faber Adrianne   Michel van Agthoven  

CNS Drugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 157-170

Adis International

Access to resources Recommend Favorite

Clonidine Extended-Release: In Attention-Deficit Hyperactivity Disorder

By Croxtall Jamie D.  

Pediatric Drugs, Vol. 13, Iss. 5, 2011-10 ,pp. : 329-336

Adis International

Access to resources Recommend Favorite

Clonidine Extended-Release In Attention-Deficit Hyperactivity Disorder†: Profile Report

By Croxtall Jamie D.  

CNS Drugs, Vol. 26, Iss. 3, 2012-03 ,pp. : 277-279

Adis International

Access to resources Recommend Favorite

Dexmethylphenidate Extended Release: In Attention-Deficit Hyperactivity Disorder

By Robinson Dean M.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 661-668

Adis International

Access to resources Recommend Favorite

Guanfacine Extended-Release: In Attention Deficit Hyperactivity Disorder

By Muir Victoria J.   Perry Caroline M.  

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1693-1702

Adis International

Access to resources Recommend Favorite